Drug lobby, under criticism, starts media campaign
By Ginger Gibson WASHINGTON (Reuters) – The largest lobbying organization for pharmaceutical companies began running TV ads on Monday morning to improve the industry's image as criticism from U.S. President Donald Trump increases. The industry is touting developments in science by pharmaceutical companies and will spend "tens of millions" on television commercials, according to an announcement on Monday by officials of lobbying group PHRMA. Pharmaceutical companies may be facing their most difficult time ahead as criticism about the price of drugs continues to increase.
